H15.113

Clinical Causes: The exact cause is often unknown, but it may involve an immune response where the body's immune system mistakenly targets the episcleral tissue. It has been linked to autoimmune conditions such as rheumatoid arthritis and other systemic inflammatory diseases. Environmental factors like exposure to allergens or irritants can sometimes trigger episodes. In some cases, episodes occur sporadically without identifiable triggers. Genetic predisposition may play a role in the development of the condition.

Key Symptoms: Temporary redness in one or both eyes, often quite visible and diffuse. Mild discomfort or a feeling of irritation in the affected eye(s). Episodes typically last from a few hours to several days. No significant pain or vision loss usually occurs. Episodes tend to recur over time, with periods of normalcy between flare-ups.

Diagnosis Path: Diagnosis is primarily clinical, based on eye examination by an ophthalmologist. The healthcare provider will look for characteristic signs of episcleritis, such as sectoral or diffuse redness that spares the deep vessels of the eye. Additional tests are generally not necessary unless other underlying systemic conditions are suspected. In such cases, blood tests or imaging may be conducted to identify associated autoimmune or inflammatory diseases.

Treatment Protocols: Since episodes of episcleritis periodica fugax are often self-limited, treatment may focus on symptom relief and preventing recurrences. Common approaches include: - **Artificial tears** to soothe eye irritation. - **Cooling compresses** to reduce redness and discomfort. - **Non-steroidal anti-inflammatory drugs (NSAIDs)** or topical corticosteroids may be prescribed during active episodes to reduce inflammation. - Managing underlying conditions, if identified, such as controlling autoimmune diseases, can help prevent recurrent episodes. Regular follow-up with an eye specialist is recommended to monitor the condition and ensure appropriate management.